Weaker US bread consumption hits Novozymes sales
A fall in bread consumption in the US impacts sales for food enzyme leader Novozymes in the third quarter with the Danish firm reporting a 7 per cent fall in sales for this segment to DKK373 million (€50 million) this year from DKK399 million (€53.6...